Neovasc (NVCN) has a profit margin of -1173.29%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
As of the most recent data (December 2022), NVCN shows a profit margin of -1173.29%. That compares with -977.04% in the prior-year period — down 20.1% year over year. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NVCN's profit margin is now -1173.29% (was -977.04%) — a 20.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neovasc is outperforming or lagging.
The Healthcare sector average profit margin is about 13.89%. Neovasc is at -1173.29%, which is lower that average. That is roughly 8545.2% below the sector mean. Use the comparison chart on this page to see how NVCN stacks up against individual peers as well.
That compares with -977.04% in the prior-year period — down 20.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Neovasc with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Neovasc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -1173.29%) with ownership activity and broader fundamentals.